Luis Briseño-Roa

Luis Briseño-Roa, a Co-Founder & CTO at Medetia Pharmaceuticals, has a strong background in genetics, genomic engineering, and image analysis. With experience in leading teams and accelerating programs into clinics at companies like Alexion Pharmaceuticals and HiFiBiO, Luis has also conducted postdoctoral research at institutions like Ecole normale supérieure and MRC Laboratory of Molecular Biology. Luis holds a PhD in Enzyme engineering from the University of Cambridge, a Bachelor of Science in Biology from Universidad Nacional Autónoma de México, and recently completed the HEC Challenge + program at HEC Paris.